Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
Sponsor
California Cancer Consortium
Collaborators